Patents by Inventor Nils Jakob Vest Hansen
Nils Jakob Vest Hansen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11634835Abstract: Provided is a method for screening an in vitro display library for binding within a cell of a small-molecule chemical compound binding entity of the library to a protein or RNA target of interest in order to identify at least one individual chemical compound binding entity of the library that is capable of binding within the cell to the protein or RNA target of interest.Type: GrantFiled: January 16, 2020Date of Patent: April 25, 2023Assignee: VIPERGEN APSInventors: Nils Jakob Vest Hansen, Jacob Andersen, Ole Kristensen, Allan Beck Christensen, Lars Kolster Petersen
-
Publication number: 20220090051Abstract: Provided is a method for screening an in vitro display library for binding within a cell of a small-molecule chemical compound binding entity of the library to a protein or RNA target of interest in order to identify at least one individual chemical compound binding entity of the library that is capable of binding within the cell to the protein or RNA target of interest.Type: ApplicationFiled: January 16, 2020Publication date: March 24, 2022Applicant: VIPERGEN APSInventors: Nils Jakob, Vest HANSEN, Jacob ANDERSEN, Ole KRISTENSEN, Allan Beck CHRISTENSEN, Lars Kolster PETERSEN
-
Patent number: 10513700Abstract: A method for making an enriched library comprising specific nucleic acid sequence information allowing to identifying at least one binding entity that binds to at least one target wherein the specific binding entity has been present in an in vitro display library.Type: GrantFiled: November 30, 2016Date of Patent: December 24, 2019Assignee: Vipergen ApSInventors: Nils Jakob Vest Hansen, Allan Beck Christensen, Leif Kongskov Larsen, Frank Abildgaard Slok, Lars Kolster Petersen, Judith Rasmussen-Dietvorst, Peter Blakskjaer, Tara Heitner Hansen, Johan Holmkvist
-
Publication number: 20170233726Abstract: A method for making an enriched library comprising specific nucleic acid sequence information allowing to identifying at least one binding entity that binds to at least one target wherein the specific binding entity has been present in an in vitro display library.Type: ApplicationFiled: November 30, 2016Publication date: August 17, 2017Applicant: Vipergen ApSInventors: Nils Jakob Vest Hansen, Allan Beck Christensen, Leif Kongskov Larsen, Frank Abildgaard Slok, Lars Kolster Petersen, Judith Rasmussen-Dietvorst, Peter Blakskjaer, Tara Heitner Hansen, Johan Holmkvist
-
Patent number: 8598089Abstract: The present invention provides a method of synthesizing libraries of molecules which include an encoding oligonucleotide tag.Type: GrantFiled: March 4, 2011Date of Patent: December 3, 2013Assignee: GlaxoSmithKline LLCInventors: Barry Morgan, Stephen Hale, Christopher C. Arico-Muendel, Matthew Clark, Richard Wagner, David I. Israel, Malcolm L. Gefter, Dennis Benjamin, Nils Jakob Vest Hansen, Malcolm J. Kavarana, Steffan Phillip Creaser, George J. Franklin, Paolo A. Centrella, Raksha A. Acharya
-
Publication number: 20130288929Abstract: A method for making an enriched library comprising specific nucleic acid sequence information allowing to identifying at least one binding entity that binds to at least one target wherein the specific binding entity has been present in an in vitro display library.Type: ApplicationFiled: September 1, 2011Publication date: October 31, 2013Applicant: VipergenInventors: Nils Jakob Vest Hansen, Allan Beck Christensen, Leif Kongskov Larsen, Frank Abildgaard Sløk, Lars Kolster Petersen, Judith Rasmussen-Dietvorst, Peter Blakskjær, Tara Heitner Hansen, Johan Holmkvist
-
Patent number: 8410028Abstract: The present invention provides a method of synthesizing libraries of molecules which include an encoding oligonucleotide tag.Type: GrantFiled: March 18, 2011Date of Patent: April 2, 2013Assignee: GlaxoSmithKline LLCInventors: Barry Morgan, Stephen Hale, Christopher C. Arico-Muendel, Matthew Clark, Richard Wagner, David I. Israel, Malcolm L. Gefter, Dennis Benjamin, Nils Jakob Vest Hansen, Malcolm J. Kavarana, Steffan Phillip Creaser, George J. Franklin, Paolo A. Centrella, Raksha A. Acharya
-
Publication number: 20120245040Abstract: The present invention provides a method of synthesizing libraries of molecules which include an encoding oligonucleotide tag.Type: ApplicationFiled: March 4, 2011Publication date: September 27, 2012Applicant: GlaxoSmithKlineInventors: Barry Morgan, Stephen Hale, Christopher C. Arico-Muendel, Matthew Clark, Richard Wagner, David I. Israel, Malcolm L. Gefter, Dennis Benjamin, Nils Jakob Vest Hansen, Malcolm J. Kavarana, Steffen Phillip Creaser, George J. Franklin, Paolo A. Centrella, Raksha A. Acharya
-
Patent number: 8202823Abstract: Disclosed is a composition comprising a nucleic acid and a chemical compound, said composition forming a star structure defining 3 or more stems extending from a reaction center. The stems are formed by a nucleic acid duplex and the chemical compound has been formed in the reaction center as the reaction product of 3 or more chemical groups. The advantage of the composition is that a close proximity is provided between the chemical groups in the reaction center, thereby promoting a reaction. The invention also relates to a method for preparation of the composition. The advantage of the method is that it does not require the pre-synthesis of a large number of templates and that it is not dependent upon codon/anti-codon recognition for an encoded molecule to be formed.Type: GrantFiled: November 8, 2005Date of Patent: June 19, 2012Assignee: Vipergen ApSInventors: Nils Jakob Vest Hansen, Peter Blakskjaer, Margit Haahr Hansen, Lars Kolster Petersen, Tara Renee Heitner
-
Publication number: 20120071329Abstract: The present invention provides a method for identifying a compound of interest by screening libraries of molecules which include an encoding oligonucleotide tag.Type: ApplicationFiled: March 18, 2011Publication date: March 22, 2012Applicant: GlaxoSmithKline LLCInventors: Barry Morgan, Stephen Hale, Christopher C. Arico-Muendel, Matthew Clark, Richard Wagner, David I. Israel, Malcolm L. Gefter, Dennis Benjamin, Nils Jakob Vest Hansen, Malcolm J. Kavarana, Steffen Phillip Creaser, George J. Franklin, Paolo A. Centrella, Raksha A. Acharya
-
Publication number: 20110251089Abstract: The present invention provides a method of synthesizing libraries of molecules which include an encoding oligonucleotide tag.Type: ApplicationFiled: March 18, 2011Publication date: October 13, 2011Applicant: GlaxoSmithKlineInventors: Barry Morgan, Stephen Hale, Christopher C. Arico-Muendel, Matthew Clark, Richard Wagner, David I. Israel, Malcolm L. Gefter, Dennis Benjamin, Nils Jakob Vest Hansen, Malcolm J. Kavarana, Steffen Phillip Creaser, George J. Franklin, Paolo A. Centrella, Raksha A. Acharya
-
Patent number: 7989395Abstract: The present invention provides a method for identifying a compound of interest by screening libraries of molecules which include an encoding oligonucleotide tag.Type: GrantFiled: October 23, 2006Date of Patent: August 2, 2011Assignee: GlaxoSmithKline LLCInventors: Barry Morgan, Stephen Hale, Christopher C. Arico-Muendel, Matthew Clark, Richard Wagner, David I. Israel, Malcolm L. Gefter, Dennis Benjamin, Nils Jakob Vest Hansen, Malcolm J. Kavarana, Steffen Phillip Creaser, George J. Franklin, Paolo A. Centrella, Raksha A. Acharya
-
Patent number: 7972992Abstract: The present invention provides methods of synthesizing a molecule comprising a functional moiety which is operatively linked to an encoding oligonucleotide. The methods include providing an initiator compound comprising an initial functional moiety comprising n building blocks, wherein the initial functional moiety comprises at least one reactive group, and is operatively linked to an initial oligonucleotide; reacting the initiator compound with a building block comprising at least one complementary reactive group, under conditions suitable for reaction of the complementary reactive group to form a covalent bond; and reacting the initial oligonucleotide with an incoming oligonucleotide corresponding to the building block in the presence of an enzyme which catalyzes ligation of the initial oligonucleotide and the incoming oligonucleotide, under conditions suitable for ligation of the incoming oligonucleotide and the initial oligonucleotide to form an encoding oligonucleotide.Type: GrantFiled: December 17, 2004Date of Patent: July 5, 2011Assignee: Praecis Pharmaceuticals, Inc.Inventors: Barry Morgan, Stephen Hale, Christopher C. Arico-Muendel, Matthew Clark, Richard Wagner, David I. Israel, Malcolm L. Gefter, Dennis Benjamin, Nils Jakob Vest Hansen, Malcolm J. Kavarana, Steffen Phillip Creaser, George J. Franklin, Paolo A. Centrella, Raksha A. Acharya
-
Patent number: 7972994Abstract: The present invention provides methods of synthesizing libraries of molecules comprising a functional moiety which is operatively linked to an encoding oligonucleotide, wherein the encoding oligonucleotide comprises a capping sequence containing degenerate nucleotides.Type: GrantFiled: June 9, 2006Date of Patent: July 5, 2011Assignee: GlaxoSmithKline LLCInventors: Barry Morgan, Stephen Hale, Christopher C. Arico-Muendel, Matthew Clark, Richard Wagner, David I. Israel, Malcolm L. Gefter, Dennis Benjamin, Nils Jakob Vest Hansen, Malcolm J. Kavarana, Steffen Phillip Creaser, George J. Franklin, Paulo A. Centrella, Raksha A. Acharya
-
Publication number: 20110136697Abstract: The present invention provides a method of synthesizing libraries of molecules which include an encoding oligonucleotide tag.Type: ApplicationFiled: February 9, 2011Publication date: June 9, 2011Applicant: Praecis Pharmaceuticals IncorporatedInventors: Barry MORGAN, Stephen Hale, Christopher C. Arico-Muendel, Matthew Clark, Richard Wagner, David I. Israel, Malcolm L. Gefter, Dennis Benjamin, Nils Jakob Vest Hansen, Malcolm J. Kavarana, Steffen Phillip Creaser, George J. Franklin, Paolo A. Centrella, Raksha A. Acharya
-
Patent number: 7935658Abstract: The present invention provides methods of synthesizing libraries of molecules comprising a functional moiety which is operatively linked to an encoding oligonucleotide.Type: GrantFiled: October 4, 2007Date of Patent: May 3, 2011Assignee: Praecis Pharmaceuticals, Inc.Inventors: Barry Morgan, Stephen Hale, Christopher C. Arico-Muendel, Matthew Clark, Richard Wagner, David I. Israel, Malcolm L. Gefter, Dennis Benjamin, Nils Jakob Vest Hansen, Malcolm J. Kavarana, Steffen Phillip Creaser, George J. Franklin, Paolo A. Centrella, Raksha A. Acharya
-
Patent number: 7928211Abstract: The present invention provides compositions, compounds and methods for in vitro DNA display technology, allowing display of a variety of molecules, in particular molecules obtained by water incompatible mechanisms. Advantages of such methods are that combinatorial libraries can be constructed comprising molecules which are obtained through water incompatible reactions.Type: GrantFiled: May 3, 2007Date of Patent: April 19, 2011Assignee: Vipergen Pharmaceuticals APSInventors: Nils Jakob Vest Hansen, Peter Blakskjaer, Lars Kolster Petersen
-
Publication number: 20110045990Abstract: Disclosed is a composition comprising a nucleic acid and a chemical compound, said composition forming a star structure defining 3 or more stems extending from a reaction center. The stems are formed by a nucleic acid duplex and the chemical compound has been formed in the reaction center as the reaction product of 3 or more chemical groups. The advantage of the composition is that a close proximity is provided between the chemical groups in the reaction center, thereby promoting a reaction. The invention also relates to a method for preparation of the composition. The advantage of the method is that it does not require the pre-synthesis of a large number of templates and that it is not dependent upon codon/anti-codon recognition for an encoded molecule to be formed.Type: ApplicationFiled: November 8, 2005Publication date: February 24, 2011Applicant: Vipergen Parmaceiticals APSInventors: Nils Jakob Vest Hansen, Peter Blaksjaer, Margit Haahr Hansen, Lars Kolster Petersen, Tara Renee Heitner
-
Publication number: 20090239768Abstract: The present invention provides compositions, compounds and methods for in vitro DNA display technology, allowing display of a variety of molecules, in particular molecules obtained by water incompatible mechanisms. Advantages of such methods are that combinatorial libraries can be constructed comprising molecules which are obtained through water incompatible reactions.Type: ApplicationFiled: May 3, 2007Publication date: September 24, 2009Applicant: VIPERGEN ApSInventors: Nils Jakob Vest Hansen, Peter Blakskjaer, Lars Kolster Petersen
-
Publication number: 20090062147Abstract: The present invention provides a method of synthesizing libraries of molecules which include an encoding oligonucleotide tag.Type: ApplicationFiled: October 4, 2007Publication date: March 5, 2009Applicant: Praecis Pharmaceuticals IncorporatedInventors: Barry Morgan, Stephen Hale, Christopher C. Arico-Muendel, Matthew Clark, Richard Wagner, David I. Israel, Malcolm L. Gefter, Dennis Benjamin, Nils Jakob Vest Hansen, Malcolm J. Kavarana, Steffen Phillip Creaser, George J. Franklin, Paolo A. Centrella, Raksha A. Acharya